The Novartis agent showed significant reduction of migraine days in both the real-world TELESCOPE and PERISCOPE studies in patients with migraine.
from Front page feed https://ift.tt/2W96eAy
from Front page feed https://ift.tt/2W96eAy
In this podcast, Dr Heidi Moawad interviews a neurologist currently researching new, available treatments in headache medicine. from Front page feed http://bit.ly/2HVwnPv
Comments
Post a Comment